Scientists discover new series of SARS-CoV-2 Mpro inhibitors for potential new treatments against COVID-19
Design of cysteine protease inhibitors. (A) Tripeptide-based interleukin-1β converting enzyme inhibitor. (B) Main compound of Pfizer coronavirus protease reported in ...